Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 12.39B |
| Enterprise Value | 12.37B |
| P/E Ratio | 31.88 |
| PEG Ratio | -1.21 |
| Price/Sales Ratio | 4.52 |
| Price/Book Ratio | 5.93 |
| Enterprise/Revenue | 4.19 |
| Enterprise/EBITDA | 20.14 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.14 |
| Operating Margin | 0.17 |
| Return On Assets | 0.14 |
| Return On Equity | 0.17 |
| Revenue | 2.87B |
| Revenue/Share | 47.8 |
| Gross Profit | 1.83B |
| EBITDA | 679.9M |
| Net Income | 430.82M |
| Diluted EPS | 6.31 |
| Total Cash | 1.15B |
| Total Cash/Share | 17.45 |
| Total Debt | 92.16M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 3.42 |
| Book Value Per Share | 36.98 |
| 52-Week Change | 3.04 |
| 52-Week High | 264.5 |
| 52-Week Low | 155 |
| Moving Average 50 Days | 226.92 |
| Moving Average 200 Days | 211.16 |
| Average Volume | 246,171 |
| Shares Outstanding | 66.06M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 1.85 |
| Payout Ratio | 0 |
| Last Split Factor | 8:1 |
| Last Split Date | July 20, 2004 |